Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
20.54 USD | -2.49% | +1.31% | +42.87% |
May. 02 | Transcript : Kura Oncology, Inc., Q1 2024 Earnings Call, May 02, 2024 | |
May. 02 | Kura Oncology, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024 | CI |
Evolution of the average Target Price on Kura Oncology, Inc.
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Kura Oncology, Inc.
Mizuho Securities | |
Wedbush | |
BofA Securities | |
Scotiabank | |
Stifel Nicolaus | |
BTIG | |
Credit Suisse | |
Cantor Fitzgerald | |
SVB Leerink | |
Jefferies & Co. | |
HC Wainwright |
EPS Revisions
- Stock Market
- Equities
- KURA Stock
- Consensus Kura Oncology, Inc.